Paul M. Mendelman

Paul M. Mendelman

Nessuna posizione attualmente

76 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Paul M.
Mendelman
worked as a Director of Clinical Research Infectious Diseases at Merck & Co., Inc. from 1991 to 1996.
He then worked as a Vice President of Clinical Development at MedImmune LLC from 2002 to 2005.
He also held the position of Vice President of Clinical Development at MedImmune Vaccines, Inc. and Senior Vice President of Clinical Development at Telik, Inc. He was the Chief Medical Officer & EVP at LigoCyte Pharmaceuticals, Inc. and later became the Chief Medical Officer at Aridis Pharmaceuticals, Inc. He returned to Aridis Pharmaceuticals, Inc. in 2019 as the Chief Medical Officer until 2020.
From 2012 to 2017, he worked as the Vice President of Medical at Takeda Vaccines, Inc. Dr. Mendelman received his undergraduate and doctorate degrees from The Ohio State University.

Precedenti posizioni note di Paul M. Mendelman

SocietàPosizioneFine
ARIDIS PHARMACEUTICALS, INC. Direttore Tecnico/Scientifico/R&S 15/06/2020
Corporate Officer/Principal 01/01/2017
LigoCyte Pharmaceuticals, Inc. Direttore Tecnico/Scientifico/R&S 16/04/2014
Corporate Officer/Principal 01/01/2005
MERCK & CO., INC. Corporate Officer/Principal 01/01/1996
Vedi nel dettaglio l'esperienza di Paul M. Mendelman

Formazione di Paul M. Mendelman

The Ohio State University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Paul M. Mendelman

Relazioni

100 +

Relazioni di 1° grado

8

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
MERCK & CO., INC.

Health Technology

ARIDIS PHARMACEUTICALS, INC.

Health Technology

Aziende private5

Health Technology

Health Technology

Health Technology

LigoCyte Pharmaceuticals, Inc.

Health Technology

Commercial Services

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Paul M. Mendelman
-40% Offerta a tempo limitato: i nostri abbonamenti ti guidano verso i migliori investimenti di domani.
APPROFITTANE ORA